Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) has earned an average recommendation of “Reduce” from the ten ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $3.5214.
A number of equities research analysts have weighed in on DH shares. Stephens decreased their target price on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a research note on Friday, February 27th. Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Morgan Stanley reiterated an “underperform” rating and set a $3.50 price objective on shares of Definitive Healthcare in a research report on Thursday, December 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of Definitive Healthcare in a report on Wednesday, January 21st. Finally, Barclays dropped their target price on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research report on Monday, December 8th.
Check Out Our Latest Stock Report on DH
Definitive Healthcare Price Performance
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in DH. Goldman Sachs Group Inc. grew its holdings in Definitive Healthcare by 564.2% during the first quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after purchasing an additional 7,404,363 shares during the period. Arrowstreet Capital Limited Partnership purchased a new stake in Definitive Healthcare in the 2nd quarter worth approximately $4,247,000. Inspire Investing LLC raised its stake in Definitive Healthcare by 505.7% during the 4th quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock worth $2,006,000 after acquiring an additional 583,562 shares during the period. Millennium Management LLC raised its stake in Definitive Healthcare by 230.9% during the 4th quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock worth $953,000 after acquiring an additional 231,743 shares during the period. Finally, Jane Street Group LLC lifted its holdings in Definitive Healthcare by 212.4% during the second quarter. Jane Street Group LLC now owns 328,410 shares of the company’s stock valued at $1,281,000 after purchasing an additional 223,296 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors.
About Definitive Healthcare
Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.
The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.
Read More
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
